SILEXION THERAPEUTICS CORP (SLXN:NASDAQ)

$0.3573 -0.0652 (-15.432%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 73

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) News Sources

Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center

13-05-2026

yahoo.com

Silexion Therapeutics Reports Positive Preliminary Immunotherapy Findings for SIL204 in KRAS-Driven Pancreatic Cancer

14-05-2026

yahoo.com

Silexion Therapeutics Announces Exercise of Warrants for $1 Million Gross Proceeds

15-05-2026

yahoo.com

Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

18-05-2026

yahoo.com

Silexion Therapeutics Announces 1-for-10 Reverse Share Split

26-05-2026

yahoo.com

Silexion Therapeutics to Attend BIO International Convention 2026

16-06-2026

yahoo.com

Silexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center

29-07-2026

yahoo.com

Silexion Therapeutics Reports New Positive Preclinical Findings Demonstrating Multi-Mechanism Immune Sensitization by SIL204 in KRAS-Driven Cancers

04-08-2026

yahoo.com

Silexion Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

14-08-2026

yahoo.com

Silexion Therapeutics to Participate in September 2026 Industry and Investor Conferences

09-09-2026

yahoo.com

SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) Sentiment Trend

0 25 50 75 100 67 72 64 76 77 78 68 68 89 77 13-05-2026 14-05-2026 15-05-2026 18-05-2026 26-05-2026 16-06-2026 29-07-2026 04-08-2026 14-08-2026 09-09-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) FAQs

toggle

What is the current price of SILEXION THERAPEUTICS CORP (SLXN:NASDAQ)?

The current price of SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) is $0.3573.


toggle

SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) absolute price change since previous trading day?

The absolute price change of SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) since the previous trading day is $-0.0652.


toggle

SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) percentage price change since previous trading day?

The percentage price change of SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) since the previous trading day is -15.432%.


toggle

What is the most recent average sentiment score for SILEXION THERAPEUTICS CORP (SLXN:NASDAQ)?

The most recent average sentiment score for SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) is 73 out of 100.


toggle

What is the most recent average sentiment for SILEXION THERAPEUTICS CORP (SLXN:NASDAQ)?

The most recent sentiment for SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) is .


SEC-8K** Filing Available For SILEXION THERAPEUTICS CORP (SLXN:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.